Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Nanofiber Technology in the Ex Vivo Expansion of Cord Blood-Derived Hematopoietic Stem Cells Publisher Pubmed



Ferreira MSV1 ; Mousavi SH2
Authors

Source: Nanomedicine: Nanotechnology# Biology# and Medicine Published:2018


Abstract

Umbilical cord blood (CB) can be used as an alternative source of hematopoietic stem cells (HSCs) for transplantation in hematological and non-hematological disorders. Despite several recognized advantages the limited cell number in CB one unit still restricts its clinical use. The success of transplantation greatly depends on the levels of total nucleated cell and CD34+ cell counts. Thus, many ex vivo strategies have been developed within the last decade in order to solve this obstacle, with more or less success, mainly determined by the degree of difficulty related with maintaining HSCs self-renewal and stemness properties after long-term expansion. Different research groups have developed very promising and diverse CB-derived HSC expansion strategies using nanofiber scaffolds. Here we review the state-of-the-art of nanofiber technology-based CB-derived HSC expansion. © 2018 Elsevier Inc.
Other Related Docs
9. Bone Regeneration in Rat Using Polycaprolactone/Gelatin/Epinephrine Scaffold, Drug Development and Industrial Pharmacy (2021)
12. Tailoring Synthetic Polymeric Biomaterials Towards Nerve Tissue Engineering: A Review, Artificial Cells# Nanomedicine and Biotechnology (2019)